Results 81 to 90 of about 374 (122)

Nephrogenic fibrosing dermopathy in a peritoneal dialysis patient [PDF]

, 2007
Chao, C.-C., Wu, V.-C., Tsai, C.-W., Hsiao, C.-H., Chen, Y.-M.   +4 more
core   +1 more source

Histologic Comparison of Scleromyxedema and Nephrogenic Fibrosing Dermopathy [PDF]

, 2008
C. Kucher, R. Elenitsas, T. Pasha, X. Xu
core   +1 more source

Gadolinium toxicity: mechanisms, clinical manifestations, and nanoparticle role. [PDF]

Arch Toxicol
Domingo JL, Semelka RC.
europepmc   +1 more source

Nephrogenic fibrosing dermopathy and calciphylaxis with pseudoxanthoma elasticum‐like changes [PDF]

, 2006
Teddy D. Pan, Kevan G. Lewis, Brian W. Lester, Leslie Robinson‐Bostom   +3 more
core   +1 more source

Contrast-induced acute kidney injury and nephrogenic systemic fibrosis in children. [PDF]

Pediatr Nephrol
Chuah AM, Chen J, Ma AL, Fung KFK, Chan EY.   +4 more
europepmc   +1 more source

Coexistence of nephrogenic systemic fibrosis and calciphylaxis in a gadolinium-naïve, chronic haemodialysis patient. [PDF]

BMJ Case Rep
Adam MS, Jmor S, Elsayed A, Naz N.
europepmc   +1 more source

Osseous metaplasia in the setting of nephrogenic fibrosing dermopathy [PDF]

, 2005
Marta P. Pascual‐Lopez, Maximiliano Aragüés, Amaro Garcia‐Diez, Savier Fraga, Diana P. Ruiz‐Genao   +4 more
core   +1 more source

Characterizing the Real-World Risks of Kidney Injuries Associated with Chimeric Antigen Receptor T Cell Therapies-Evidence and Safety. [PDF]

Health Data Sci
Wang J, Xie T, Peng J, Zhang Y, Zhang H.
europepmc   +1 more source

Gadolinium-Induced Nephrogenic Systemic Fibrosis. [PDF]

Methodist Debakey Cardiovasc J, 2017
Shah AH, Olivero JJ.
europepmc   +1 more source

Clinical, mechanistic, and therapeutic landscape of cutaneous fibrosis. [PDF]

Sci Transl Med
Li DJ, Berry CE, Wan DC, Longaker MT.
europepmc   +1 more source